UPDATE: Lexicon Pharmaceuticals (LXRX) Has More Upside, PT Raised to $13 at Citi
Tweet Send to a Friend
(Updated - January 15, 2021 7:44 AM EST)
Citi analyst Yigal Nochomovitz raised the price target on Lexicon Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst Yigal Nochomovitz raised the price target on Lexicon Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
